UNSPSC 51183512: Metformin orotate

This classification denotes an anti-diabetic agent with the molecular formula C5H4N2O4.C4H11N5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KE1D8AP3J5, chemically known as 4-pyrimidinecarboxylic acid, 1,2,3,6-tetrahydro-2,6-dioxo-, compd. with n,n-dimethylimidodicarbonimidic diamide (1:1), but more generally known as metformin orotate, which bears US NIH Compound Identifier 124097.

European Medicines Agency schedules metformin orotate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08831MIG. Most nations, for tariff purposes, schedule metformin orotate under HS 29252900. SMILES: CN(C)C(=N)NC(=N)N.C1C([NH]C(=O)[NH]C1=O)C(=O)O.

UNSPSC 51183512 Metformin orotate, a Commodity code, covers the procurement of this specific pharmaceutical formulation by state and local health agencies, corrections departments, and public health systems. Metformin orotate is a combination salt of the antidiabetic agent metformin paired with orotic acid, used in diabetes management and sold as a branded pharmaceutical in some markets. State and local buyers procure this drug through health-system formularies, correctional-facility medical supplies contracts, and public health insurance programs serving Medicaid-eligible populations. The code sees activity from state health departments, county hospitals and clinics, city public-health agencies, and independent school districts with student health services, though issuing bodies typically consolidate pharmaceutical procurement through centralized statewide contracts or regional group purchasing organizations rather than issuing individual solicitations per drug.

No recent state or local contract opportunities are present in the source for UNSPSC 51183512 Metformin orotate. This narrow Commodity code reflects specialized pharmaceutical procurement that state and local buyers typically conduct through standing master service agreements with pharmaceutical wholesalers or through cooperative purchasing vehicles such as NASPO ValuePoint or regional hospital consortia, rather than through competitive notice-posted solicitations visible in public procurement databases.